NewzA new federal customs rule scheduled to take effect later this month is expected to restrict American access to lower-cost prescription drugs imported from Canada. The policy change is projected to increase costs for millions of U.S. consumers who currently rely on these international sources for more affordable medication.
The impending regulation has drawn bipartisan criticism from lawmakers in the United States. Opponents of the rule have raised concerns regarding the potential impact on household budgets, particularly as the country continues to navigate broader challenges related to the cost of living.
In-depth summary · AI, neutral